Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pegfilgrastim”

157 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 157 results

Testing effectiveness (Phase 2)Study completedNCT00066443
What this trial is testing

Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
NCIC Clinical Trials Group 93
Large-scale testing (Phase 3)UnknownNCT03404752
What this trial is testing

Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients.

Who this might be right for
Breast Cancer
Gema Biotech S.A. 120
Early research (Phase 1)Active Not RecruitingNCT06918587
What this trial is testing

Open Label Randomized Comparative Crossover Pharmacokinetic and Immunogenicity Study

Who this might be right for
Febrile Neutropenia
Kashiv BioSciences, LLC 180
Early research (Phase 1)UnknownNCT04651036
What this trial is testing

Assess the Immunogenicity of QL0605 Compared to US Neulasta in Healthy Subjects

Who this might be right for
Healthy
Qilu Pharmaceutical Co., Ltd. 300
Testing effectiveness (Phase 2)Study completedNCT00470366
What this trial is testing

Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors

Who this might be right for
Brain and Central Nervous System TumorsExtragonadal Germ Cell TumorOvarian Cancer+2 more
Memorial Sloan Kettering Cancer Center 60
Very early researchEnded earlyNCT02392039
What this trial is testing

Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 1
Not applicableStudy completedNCT00615901
What this trial is testing

Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 38
Testing effectiveness (Phase 2)Study completedNCT00031629
What this trial is testing

Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus

Who this might be right for
Recurrent Uterine Corpus SarcomaUterine Corpus Leiomyosarcoma
Gynecologic Oncology Group 51
Testing effectiveness (Phase 2)Study completedNCT01724866
What this trial is testing

Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer

Who this might be right for
Neutropenia
Spectrum Pharmaceuticals, Inc 148
Early research (Phase 1)Study completedNCT04873765
What this trial is testing

Biosimilarity Study of Subcutaneous Pegfilgrastim in Healthy Volunteers

Who this might be right for
Neutropenia
Megalabs 72
Early research (Phase 1)Study completedNCT03251339
What this trial is testing

Safety and Immunogenicity of MSB11455 in Healthy Participants

Who this might be right for
Healthy
Fresenius Kabi SwissBioSim GmbH 336
Large-scale testing (Phase 3)Study completedNCT00117910
What this trial is testing

Treatment for Elderly Patients With High Risk Breast Cancer

Who this might be right for
Breast Cancer
Amgen
Testing effectiveness (Phase 2)Study completedNCT00101127
What this trial is testing

Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma

Who this might be right for
Sarcoma
Gynecologic Oncology Group
Not applicableStudy completedNCT00094822
What this trial is testing

Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung CancerNon-Small Cell Lung Cancer
Amgen 90
Testing effectiveness (Phase 2)Study completedNCT01266447
What this trial is testing

Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Small Cell Carcinoma+5 more
National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Study completedNCT00306111
What this trial is testing

Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
University Hospital Tuebingen 14
Early research (Phase 1)UnknownNCT02205320
What this trial is testing

A Comparative, Crossover, Pharmacokinetic, Pharmacodynamic and Safety Study of Three Forms of PEG-G-CSF in Normal Healthy Volunteers

Who this might be right for
Pharmacokinetics
Dr. Reddy's Laboratories Limited 192
Large-scale testing (Phase 3)Study completedNCT02953340
What this trial is testing

SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide

Who this might be right for
NeutropeniaBreast Cancer
Spectrum Pharmaceuticals, Inc 237
Large-scale testing (Phase 3)Study completedNCT00151242
What this trial is testing

Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
University of Ulm 920
Testing effectiveness (Phase 2)Study completedNCT00067639
What this trial is testing

Pegfilgrastim (Neulasta) for Stem Cell Mobilization in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
M.D. Anderson Cancer Center 50
Load More Results